These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21067836)

  • 1. The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes.
    Zhang Y; Vitry A; Caughey G; Roughead EE; Ryan P; Gilbert A; Shakib S; McDermott R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):115-20. PubMed ID: 21067836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts.
    Caughey GE; Roughead EE; Vitry AI; McDermott RA; Shakib S; Gilbert AL
    Diabetes Res Clin Pract; 2010 Mar; 87(3):385-93. PubMed ID: 19923032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers.
    Maciejewski ML; Livingston EH; Kahwati LC; Henderson WG; Kavee AL; Arterburn DE
    Surg Obes Relat Dis; 2010; 6(6):601-7. PubMed ID: 20965791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-morbidity and the utilization of health care for Australian veterans with diabetes.
    Zhang Y; Vitry A; Roughead E; Ryan P; Gilbert A
    Diabet Med; 2010 Jan; 27(1):65-71. PubMed ID: 20121891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
    Ademi Z; Liew D; Hollingsworth B; Steg PG; Bhatt DL; Reid CM;
    Am J Cardiovasc Drugs; 2010; 10(2):85-94. PubMed ID: 20334445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease.
    Roughead EE; Vitry AI; Preiss AK; Barratt JD; Gilbert AL; Ryan P
    Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):71-6. PubMed ID: 19587601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
    Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment and cost of cardiovascular disease in Australia.
    Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
    Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy for the patient with obesity.
    Bray GA; Ryan DH
    Circulation; 2012 Apr; 125(13):1695-703. PubMed ID: 22474312
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of stroke, heart attack, and diabetes complications among veterans with spinal cord injury.
    Banerjea R; Sambamoorthi U; Weaver F; Maney M; Pogach LM; Findley T
    Arch Phys Med Rehabil; 2008 Aug; 89(8):1448-53. PubMed ID: 18674979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes.
    Roughead EE; Pratt N; Gilbert AL
    Br J Clin Pharmacol; 2007 Jul; 64(1):100-4. PubMed ID: 17298476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study.
    Wakkee M; Meijer W; Neumann HA; Herings RM; Nijsten T
    Acta Derm Venereol; 2009; 89(5):476-83. PubMed ID: 19734972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients.
    Glintborg B; Hillestrøm PR; Olsen LH; Dalhoff KP; Poulsen HE
    J Clin Pharmacol; 2007 Nov; 47(11):1440-9. PubMed ID: 17962430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a gender and age inequality in the prescribing of preventative cardiovascular therapies to the elderly in primary care.
    Usher C; Bennett K; Feely J
    Age Ageing; 2004 Sep; 33(5):500-2. PubMed ID: 15315919
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugs.
    Sirois C; Moisan J; Poirier P; Couture J; Gregoire JP
    Age Ageing; 2009 Nov; 38(6):741-5. PubMed ID: 19759258
    [No Abstract]   [Full Text] [Related]  

  • 17. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prescribed drugs and diagnoses in over 60-year-old persons exemplified by cardiovascular diseases. Follow-up studies using federal health insurance data].
    von Ferber L; Köster I; Schubert I
    Z Gerontol Geriatr; 1995; 28(6):401-7. PubMed ID: 8581758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.
    Johnson ML; Pietz K; Battleman DS; Beyth RJ
    Am J Manag Care; 2004 Dec; 10(12):926-32. PubMed ID: 15617368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.